您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8420 处方药 8047 非处方药 267 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 泌尿生殖系统及泌乳药物->泌尿系统结石
处方药:处方药
包装规格: 1080毫克/片 100片/瓶
计价单位:
  点击放大  
生产厂家中文参考译名:
美国Mission 制药公司
生产厂家英文名:
Mission Pharmacal Corporation,USA
该药品相关信息网址1:
http://www.urocit-k.com/Index.aspx
该药品相关信息网址2:
http://store.pets-life-rx.com/urocit-k.html
原产地英文商品名:
UROCIT-K(10 MEQ TABS)SA 1080mg/tab 100tabs/bottle
原产地英文药品名:
POTASSIUM CITRATE
中文参考商品译名:
UROCIT-K(10 MEQ TABS)缓释片 1080毫克/片 100片/瓶
中文参考药品译名:
枸橼酸钾
原产地国家批准上市年份:
1985/08/30
英文适应病症1:
urinary stone
英文适应病症2:
calcium and uric acid kidney stones
临床试验期:
完成
中文适应病症参考翻译1:
尿道结石
中文适应病症参考翻译2:
钙和尿酸肾结石
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(2010122018000235.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文Urocit-k处方资料(仅供参考)

Urocit-kâ是一種檸檬酸鉀的緩慢釋放型製劑,經由臨床研究結果發現, 在低檸檬酸尿結石的病人, 服用Urocit-kâ可以增加尿中的pH, 鉀離子和檸檬酸。 而在正常的志願者, Urocit-kâ發揮了它緩慢釋出的特性, 因為它能穩定地提昇尿中的pH值和鉀離子達8小時, 提昇檸檬酸濃度更幾乎達24小時。 在試驗過程中, 並沒有明顯的併發症, 諸如腸胃道或心肺機能的不適。 所以本研究的結論是Urocit-kâ是一種檸檬酸鉀的優良製劑, 同時也是預防尿石復發的良好選擇。
Urocit-kâ亦經由其他國內外臨床報告顯示檸檬酸為抑制尿路結石形成之因子,使用Urocit-K可以增加尿中pH值,鉀離子和檸檬酸,並發揮緩慢釋出的特性,減少可能之併發症,本院臨床亦顯示同樣結果,在實驗過程中無明顯的併發症,副作用非常小。所以依臨床研究結論Urocit-K的緩釋特性能穩定增加urinary citrate之排泄,而無一般製劑之週期,起伏變動,為防止尿結石復發,提供良好選擇。
Urocit-KÒ克石聖錠主治下述各症狀之預防及再發:
l        有鈣石症之腎小管酸中毒症。
l        任何病因引起的低檸檬草酸鈣腎結石症。
l        有或沒有鈣石之尿酸腎石症。 
Urocit-K之治療目標為提供足夠劑量以恢復正常尿液中檸檬酸鹽之濃度(大於320mg/day,盡量接近正常值640mg/day),並提昇pH值至6.0~7.0。 
劑量:依照醫師指示,一般用法為一天兩次,每次一至二顆
注意事項:服用Urocit-K需限制鹽分之攝取,並鼓勵攝取大量液體。 
副作用:部份患者曾有輕微胃腸不適的抱怨,可以降低劑量或與食物併服來減輕症狀。

Urocit®-K (potassium citrate)
To Help Protect You From Another Kidney Stone Attack
If you've ever suffered from a kidney stone attack you will probably do anything in your power to prevent a recurrence. Luckily there's a specific preventative medical treatment that can greatly reduce the likelihood of your having another stone attack: Urocit®-K.
 Urocit®-K is a formulation of potassium citrate. Urocit®-K is available in slow-release wax-matrix tablets in 540 mg and 1080 mg strengths. Urocit®-K is indicated for the treatment of calcium and uric acid kidney stones.
Urocit®-K is clinically proven to inhibit the formation of most stones in over 90% of patients.

How Urocit®-K Works
Urocit®-K corrects the pH of the urine and elevates a naturally occurring urinary inhibitor. This helps control the formation of new stones.

Urocit®-K's Delivery System
Urocit®-K utilizes a wax-matrix delivery system. This wax-matrix system delivers a slow, sustained release of medication which allows for convenient dosing, less gastrointestinal upset, and enhanced patient compliance.

How does Urocit®-K work?
The potassium citrate in Urocit®-K works partly by restoring the naturally occurring chemicals that block the formation of stones.
Urocit®-K normalizes the urinary environment so that calcium stone formation is inhibited and crystals don't form.
Urocit®-K also reduces the tendency of uric acid to form stones. Most patients with this type of stone, when treated with Urocit®-K, do not form stones at all. In those who still form stones, the stones develop at a lower rate than before treatment.

The wax matrix system
Urocit®-K contains potassium citrate in a wax-matrix tablet. This wax-matrix system delivers a slow, sustained release of medication which allows for less frequent dosing — once in the morning and once at night, or as prescribed by your physician.
Also, the slow-release tablets are better tolerated than liquid preparations so there is less stomach upset.
The wax-matrix tablets, unlike powder forms, offer the added convenience of not having to be reconstituted with water. And, there are no bottles of liquid to break or spill.


---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(2010122018000235.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新于2010年12月21日

更新日期: 2010-12-21
附件:
2010122018000235.pdf    







 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com